Ad Scientiam

Paris, France

Ad Scientiam develop reliable solutions to measure disease evolution to accelerate treatment decisions to fight the disabilities.

$5.7M raised

Nov 2025

Venture - Series Unknown

Top Investors

Bedex et AssociésBIODIGITAL PARTICIPATIONSTechlife Capital

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Ad Scientiam raised?

Ad Scientiam has raised $5.7M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2025.

Who are Ad Scientiam's investors?

Ad Scientiam's investors include Bedex et Associés, BIODIGITAL PARTICIPATIONS, Techlife Capital.

Where is Ad Scientiam headquartered?

Ad Scientiam is headquartered in Paris, France.

What does Ad Scientiam do?

Ad Scientiam develop reliable solutions to measure disease evolution to accelerate treatment decisions to fight the disabilities.

What stage is Ad Scientiam at?

Ad Scientiam is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 5, 2025.

MLA

"Ad Scientiam — Funding & Investors." VCBacked, November 5, 2025, https://www.vcbacked.co/company/ad-scientiam. Accessed June 4, 2026.

APA

VCBacked. (2025). Ad Scientiam — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/ad-scientiam

Wikipedia (cite web)

{{cite web |title=Ad Scientiam — Funding & Investors |url=https://www.vcbacked.co/company/ad-scientiam |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 5, 2025.